BTCY
Income statement / Annual
Last year (2024), Biotricity, Inc.'s total revenue was $12.06 M,
an increase of 25.15% from the previous year.
In 2024, Biotricity, Inc.'s net income was -$14.09 M.
See Biotricity, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
12/31/2015 |
08/31/2015 |
Operating Revenue |
$12.06 M |
$9.64 M |
$7.65 M |
$3.38 M |
$1.42 M |
$398,200.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$3.71 M
|
$4.20 M
|
$3.08 M
|
$2.11 M
|
$931,951.00
|
$338,335.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$8.36 M
|
$5.44 M
|
$4.57 M
|
$1.27 M
|
$485,774.00
|
$59,865.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0.69
|
0.57
|
0.6
|
0.38
|
0.34
|
0.15
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$2.57 M
|
$3.23 M
|
$2.74 M
|
$2.06 M
|
$1.36 M
|
$1.31 M
|
$1.76 M
|
$1.14 M
|
$1.14 M
|
$23,200.00
|
General & Administrative Expenses |
$14.61 M
|
$17.62 M
|
$18.56 M
|
$12.57 M
|
$10.05 M
|
$7.34 M
|
$5.96 M
|
$4.80 M
|
$3.99 M
|
$56,087.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$14.61 M
|
$17.62 M
|
$18.56 M
|
$12.57 M
|
$10.05 M
|
$7.34 M
|
$5.96 M
|
$4.80 M
|
$3.99 M
|
$56,087.00
|
Other Expenses |
$0.00
|
-$181,941.00
|
-$1.14 M
|
-$67,099.00
|
$16,939.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$1,215.00
|
Operating Expenses |
$17.18 M
|
$20.85 M
|
$21.31 M
|
$14.62 M
|
$11.42 M
|
$8.65 M
|
$7.72 M
|
$5.94 M
|
$5.13 M
|
$89,598.00
|
Cost And Expenses |
$20.89 M
|
$25.05 M
|
$24.39 M
|
$16.74 M
|
$12.35 M
|
$8.99 M
|
$7.72 M
|
$5.94 M
|
$5.13 M
|
$89,598.00
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$5.19 M
|
$2.58 M
|
$10.57 M
|
$2.48 M
|
$92,416.00
|
$0.00
|
$879,416.00
|
$1.18 M
|
$59,875.00
|
$0.00
|
Depreciation & Amortization |
$5,953.00
|
$346,260.00
|
$68,339.00
|
$347,116.00
|
$148,764.00
|
$8.58 M
|
$7.72 M
|
$5.94 M
|
$9,051.00
|
$810.00
|
EBITDA |
-$8.90 M |
-$15.40 M |
-$18.02 M |
-$13.35 M |
-$10.93 M |
-$8.59 M |
$0.00 |
-$5.94 M |
-$5.12 M |
$0.00 |
EBITDA Ratio |
-0.74
|
-1.62
|
-2.34
|
-3.96
|
-7.7
|
-21.58
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
-0.73
|
-1.62
|
-2.34
|
-3.96
|
-7.7
|
-21.58
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$5.27 M
|
-$3.25 M
|
-$12.39 M
|
-$2.78 M
|
-$136,258.00
|
$0.00
|
-$900,004.00
|
-$1.87 M
|
-$55,849.00
|
$7.00
|
Income Before Tax |
-$14.09 M
|
-$18.66 M
|
-$29.13 M
|
-$15.49 M
|
-$11.07 M
|
-$8.59 M
|
-$8.62 M
|
-$7.81 M
|
-$5.19 M
|
-$90,813.00
|
Income Before Tax Ratio |
-1.17
|
-1.94
|
-3.81
|
-4.58
|
-7.81
|
-21.58
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$2.40 M
|
$9.43 M
|
$2.07 M
|
-$39,409.00
|
-$171,860.00
|
-$6.84 M
|
-$4.76 M
|
$50,824.00
|
-$810.00
|
Net Income |
-$14.09 M
|
-$18.66 M
|
-$29.13 M
|
-$15.49 M
|
-$11.07 M
|
-$8.59 M
|
-$8.62 M
|
-$7.81 M
|
-$5.19 M
|
-$90,813.00
|
Net Income Ratio |
-1.17
|
-1.94
|
-3.81
|
-4.58
|
-7.81
|
-21.58
|
0
|
0
|
0
|
0
|
EPS |
-1.66 |
-2.15 |
-3.85 |
-2.48 |
-1.85 |
-1.54 |
-1.72 |
-1.81 |
-1.42 |
-0.0605 |
EPS Diluted |
-1.66 |
-2.15 |
-3.85 |
-2.48 |
-1.85 |
-1.54 |
-1.72 |
-1.81 |
-1.42 |
-0.0605 |
Weighted Average Shares Out |
$8.99 M
|
$8.66 M
|
$7.57 M
|
$6.25 M
|
$5.99 M
|
$5.56 M
|
$5.03 M
|
$4.31 M
|
$3.64 M
|
$1.50 M
|
Weighted Average Shares Out Diluted |
$8.99 M
|
$8.66 M
|
$7.57 M
|
$6.25 M
|
$5.99 M
|
$5.56 M
|
$5.03 M
|
$4.31 M
|
$3.64 M
|
$1.50 M
|
Link |
|
|
|
|
|
|
|
|
|
|